思创医惠(300078.SZ)：2024年年报净利润为-5.02亿元

Core Insights - The company reported a total revenue of 691 million yuan for 2024, a decrease of 315 million yuan compared to the previous year, representing a year-on-year decline of 31.33% [1] - The net profit attributable to shareholders was -502 million yuan, ranking 118 among peers [1] - The operating cash flow showed a net outflow of 35.68 million yuan, a decrease of 47.47 million yuan year-on-year, reflecting a decline of 402.72% [1] Financial Performance - The latest debt-to-asset ratio stands at 73.11%, ranking 120 among peers [3] - The gross profit margin is reported at 12.14%, ranking 118 among peers [3] - The return on equity (ROE) is -86.50%, ranking 126 among peers [3] Earnings and Ratios - The diluted earnings per share is -0.53 yuan, ranking 101 among peers [4] - The total asset turnover ratio is 0.29 times, a decrease of 0.03 times year-on-year, reflecting a decline of 10.58% [4] - The inventory turnover ratio is 3.08 times, ranking 75 among peers [4] Shareholder Information - The number of shareholders is 48,700, with the top ten shareholders holding 291 million shares, accounting for 25.85% of the total share capital [4] - The largest shareholder is 苍南县思加物联智能合伙企业(有限合伙) with a holding of 5.68% [4] Research and Development - The total R&D investment is 102 million yuan, ranking 5th in the last five years, with a decrease of 53.56 million yuan year-on-year, representing a decline of 34.49% [4] - The latest R&D investment ratio is 14.73%, ranking 4th in the last five years, with a decrease of 0.71 percentage points year-on-year [4]